Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-11-26

Clinical Trial Update: Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions [Phase 4]

View source ↗

Summary

A Phase 4 clinical study is evaluating whether a saw palmetto preparation influences sexual dysfunction in men with benign prostatic hyperplasia. The sponsor is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saw Palmetto (Serenoa repens)

Snippet

Sponsor: A. Vogel AG | Conditions: Sexual Dysfunctions in Men With Benign Prostatic Hyperplasia | Phase 4 | Status: UNKNOWN